 | • レポートコード：QYR9ST04753 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん胎児性抗原（CEA）の世界市場について調査・分析し、がん胎児性抗原（CEA）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f）、用途別（大腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん胎児性抗原（CEA）市場動向 ・主要企業別マーケットシェア ・がん胎児性抗原（CEA）の種類別市場規模2014-2019 （CD66a、CD66b、CD66c、CD66d、CD66e、CD66f） ・がん胎児性抗原（CEA）の用途別市場規模2014-2019 （大腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん、その他） ・がん胎児性抗原（CEA）の北米市場：主要企業・種類別/用途別市場規模 ・がん胎児性抗原（CEA）のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん胎児性抗原（CEA）の中国市場：主要企業・種類別/用途別市場規模 ・がん胎児性抗原（CEA）の日本国内市場：主要企業・種類別/用途別市場規模 ・がん胎児性抗原（CEA）の東南アジア市場：主要企業・種類別/用途別市場規模 ・がん胎児性抗原（CEA）のインド市場：主要企業・種類別/用途別市場規模 ・がん胎児性抗原（CEA）の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Roche Diagnostics、Abbott Diagnostics、Quest Diagnostics） ・がん胎児性抗原（CEA）の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
In 2018, the global Carcinoembryonic Antigen (CEA) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Carcinoembryonic Antigen (CEA) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Carcinoembryonic Antigen (CEA) development in United States, Europe and China.
The key players covered in this study
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
…
Market segment by Type, the product can be split into
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Market segment by Application, split into
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Carcinoembryonic Antigen (CEA) status, future forecast, growth opportunity, key market and key players.
To present the Carcinoembryonic Antigen (CEA) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Carcinoembryonic Antigen (CEA) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type (2014-2025)
1.4.2 CD66a
1.4.3 CD66b
1.4.4 CD66c
1.4.5 CD66d
1.4.6 CD66e
1.4.7 CD66f
1.5 Market by Application
1.5.1 Global Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2025)
1.5.2 Colorectal Cancer
1.5.3 Pancreatic Cancer
1.5.4 Ovarian Cancer
1.5.5 Breast Cancer
1.5.6 Thyroid Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Carcinoembryonic Antigen (CEA) Market Size
2.2 Carcinoembryonic Antigen (CEA) Growth Trends by Regions
2.2.1 Carcinoembryonic Antigen (CEA) Market Size by Regions (2014-2025)
2.2.2 Carcinoembryonic Antigen (CEA) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Carcinoembryonic Antigen (CEA) Market Size by Manufacturers
3.1.1 Global Carcinoembryonic Antigen (CEA) Revenue by Manufacturers (2014-2019)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.2 Carcinoembryonic Antigen (CEA) Key Players Head office and Area Served
3.3 Key Players Carcinoembryonic Antigen (CEA) Product/Solution/Service
3.4 Date of Enter into Carcinoembryonic Antigen (CEA) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019)
4.2 Global Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019)
5 United States
5.1 United States Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
5.2 Carcinoembryonic Antigen (CEA) Key Players in United States
5.3 United States Carcinoembryonic Antigen (CEA) Market Size by Type
5.4 United States Carcinoembryonic Antigen (CEA) Market Size by Application
6 Europe
6.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
6.2 Carcinoembryonic Antigen (CEA) Key Players in Europe
6.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Type
6.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Application
7 China
7.1 China Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
7.2 Carcinoembryonic Antigen (CEA) Key Players in China
7.3 China Carcinoembryonic Antigen (CEA) Market Size by Type
7.4 China Carcinoembryonic Antigen (CEA) Market Size by Application
8 Japan
8.1 Japan Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
8.2 Carcinoembryonic Antigen (CEA) Key Players in Japan
8.3 Japan Carcinoembryonic Antigen (CEA) Market Size by Type
8.4 Japan Carcinoembryonic Antigen (CEA) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
9.2 Carcinoembryonic Antigen (CEA) Key Players in Southeast Asia
9.3 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type
9.4 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application
10 India
10.1 India Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
10.2 Carcinoembryonic Antigen (CEA) Key Players in India
10.3 India Carcinoembryonic Antigen (CEA) Market Size by Type
10.4 India Carcinoembryonic Antigen (CEA) Market Size by Application
11 Central & South America
11.1 Central & South America Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
11.2 Carcinoembryonic Antigen (CEA) Key Players in Central & South America
11.3 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Type
11.4 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Application
12 International Players Profiles
12.1 Roche Diagnostics
12.1.1 Roche Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Carcinoembryonic Antigen (CEA) Introduction
12.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019)
12.1.5 Roche Diagnostics Recent Development
12.2 Abbott Diagnostics
12.2.1 Abbott Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Carcinoembryonic Antigen (CEA) Introduction
12.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019)
12.2.5 Abbott Diagnostics Recent Development
12.3 Quest Diagnostics
12.3.1 Quest Diagnostics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Carcinoembryonic Antigen (CEA) Introduction
12.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019)
12.3.5 Quest Diagnostics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Carcinoembryonic Antigen (CEA) Key Market Segments
Table Key Players Carcinoembryonic Antigen (CEA) Covered
Table Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Type 2014-2025
Figure CD66a Figures
Table Key Players of CD66a
Figure CD66b Figures
Table Key Players of CD66b
Figure CD66c Figures
Table Key Players of CD66c
Figure CD66d Figures
Table Key Players of CD66d
Figure CD66e Figures
Table Key Players of CD66e
Figure CD66f Figures
Table Key Players of CD66f
Table Global Carcinoembryonic Antigen (CEA) Market Size Growth by Application 2014-2025 (Million US$)
Figure Colorectal Cancer Case Studies
Figure Pancreatic Cancer Case Studies
Figure Ovarian Cancer Case Studies
Figure Breast Cancer Case Studies
Figure Thyroid Cancer Case Studies
Figure Others Case Studies
Figure Carcinoembryonic Antigen (CEA) Report Years Considered
Table Global Carcinoembryonic Antigen (CEA) Market Size 2014-2025 (Million US$)
Figure Global Carcinoembryonic Antigen (CEA) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Carcinoembryonic Antigen (CEA) Market Size by Regions 2014-2025 (Million US$)
Table Global Carcinoembryonic Antigen (CEA) Market Size by Regions 2014-2019 (Million US$)
Table Global Carcinoembryonic Antigen (CEA) Market Share by Regions 2014-2019
Figure Global Carcinoembryonic Antigen (CEA) Market Share by Regions 2014-2019
Figure Global Carcinoembryonic Antigen (CEA) Market Share by Regions 2019
Table Market Top Trends
Table Global Carcinoembryonic Antigen (CEA) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Carcinoembryonic Antigen (CEA) Market Share by Manufacturers (2014-2019)
Figure Global Carcinoembryonic Antigen (CEA) Market Share by Manufacturers in 2018
Table Global Carcinoembryonic Antigen (CEA) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Carcinoembryonic Antigen (CEA) Product/Solution/Service
Table Date of Enter into Carcinoembryonic Antigen (CEA) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019) (Million US$)
Table Global Carcinoembryonic Antigen (CEA) Market Size Share by Type (2014-2019)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Type (2014-2019)
Table Global Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019) (Million US$)
Table Global Carcinoembryonic Antigen (CEA) Market Size Share by Application (2014-2019)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Application (2014-2019)
Figure Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Application in 2018
Figure United States Carcinoembryonic Antigen (CEA) Market Size 2014-2019 (Million US$)
Table United States Key Players Carcinoembryonic Antigen (CEA) Revenue (2018-2019) (Million US$)
Table United States Key Players Carcinoembryonic Antigen (CEA) Market Share (2018-2019)
Table United States Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019) (Million US$)
Table United States Carcinoembryonic Antigen (CEA) Market Share by Type (2014-2019)
Table United States Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019) (Million US$)
Table United States Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2019)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size 2014-2019 (Million US$)
Table Europe Key Players Carcinoembryonic Antigen (CEA) Revenue (2018-2019) (Million US$)
Table Europe Key Players Carcinoembryonic Antigen (CEA) Market Share (2018-2019)
Table Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019) (Million US$)
Table Europe Carcinoembryonic Antigen (CEA) Market Share by Type (2014-2019)
Table Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019) (Million US$)
Table Europe Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2019)
Figure China Carcinoembryonic Antigen (CEA) Market Size 2014-2019 (Million US$)
Table China Key Players Carcinoembryonic Antigen (CEA) Revenue (2018-2019) (Million US$)
Table China Key Players Carcinoembryonic Antigen (CEA) Market Share (2018-2019)
Table China Carcinoembryonic Antigen (CEA) Market Size by Type (2014-20189) (Million US$)
Table China Carcinoembryonic Antigen (CEA) Market Share by Type (2014-2019)
Table China Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019) (Million US$)
Table China Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2019)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size 2014-2019 (Million US$)
Table Japan Key Players Carcinoembryonic Antigen (CEA) Revenue (2018-2019) (Million US$)
Table Japan Key Players Carcinoembryonic Antigen (CEA) Market Share (2018-2019)
Table Japan Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019) (Million US$)
Table Japan Carcinoembryonic Antigen (CEA) Market Share by Type (2014-2019)
Table Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019) (Million US$)
Table Japan Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2019)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Carcinoembryonic Antigen (CEA) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Carcinoembryonic Antigen (CEA) Market Share (2018-2019)
Table Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Carcinoembryonic Antigen (CEA) Market Share by Type (2014-2019)
Table Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2019)
Figure India Carcinoembryonic Antigen (CEA) Market Size 2014-2019 (Million US$)
Table India Key Players Carcinoembryonic Antigen (CEA) Revenue (2018-2019) (Million US$)
Table India Key Players Carcinoembryonic Antigen (CEA) Market Share (2018-2019)
Table India Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019) (Million US$)
Table India Carcinoembryonic Antigen (CEA) Market Share by Type (2014-2019)
Table India Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019) (Million US$)
Table India Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2019)
Figure Central & South America Carcinoembryonic Antigen (CEA) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Carcinoembryonic Antigen (CEA) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Carcinoembryonic Antigen (CEA) Market Share (2018-2019)
Table Central & South America Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Carcinoembryonic Antigen (CEA) Market Share by Type (2014-2019)
Table Central & South America Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2019)
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019) (Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2014-2019)
Table Roche Diagnostics Recent Development
Table Abbott Diagnostics Company Details
Table Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019)(Million US$)
Figure Abbott Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2014-2019)
Table Abbott Diagnostics Recent Development
Table Quest Diagnostics Company Details
Table Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019)(Million US$)
Figure Quest Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2014-2019)
Table Quest Diagnostics Recent Development
Table Global Carcinoembryonic Antigen (CEA) Market Size by Regions (Million US$) 2019-2025
Figure Global Carcinoembryonic Antigen (CEA) Market Size Share by Regions (2019-2025)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Share by Regions in 2025
Figure United States Carcinoembryonic Antigen (CEA) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size Forecast (2019-2025)(Million USD)
Figure China Carcinoembryonic Antigen (CEA) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size Forecast (2019-2025)(Million USD)
Figure India Carcinoembryonic Antigen (CEA) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Carcinoembryonic Antigen (CEA) Market Size Forecast (2019-2025)(Million USD)
Table Global Carcinoembryonic Antigen (CEA) Market Size by Product (2019-2025) (Million US$)
Figure Global Carcinoembryonic Antigen (CEA) Market Size by Product (2019-2025)
Figure Global Carcinoembryonic Antigen (CEA) Market Size by Product in 2025
Table Global Carcinoembryonic Antigen (CEA) Market Size by Application (2019-2025) (Million US$)
Figure Global Carcinoembryonic Antigen (CEA) Market Size by Application (2019-2025)
Figure Global Carcinoembryonic Antigen (CEA) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
卵巣癌遺伝子治療の世界市場：市場規模・現状・予測 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- 卵巣癌の世界市場：市場規模・現状・予測 Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.North America dominates the global market for ovarian cancer due to large number of aging p…
- 膵臓癌治療の世界市場：市場規模・現状・予測 Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 卵巣癌治療の世界市場：市場規模・現状・予測 Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products.In 2018, the global Ovarian Cancer Th…
- 体外大腸癌スクリーニング検査の世界市場：市場規模・現状・予測 In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.Growing incidences of colon and rectal cancer and the introduction of novel screening tests employing genetic testing are the major factors expected to drive the in-vitro colorectal can…